Ken Griffin acquired 529 Thousand Apellis Pharmaceuticals shares worth $20.5 Million. That's 0.03% of their equity portfolio (712th largest holding). The first Apellis Pharmaceuticals trade was made in Q2 2018. Since then Ken Griffin bought shares ten more times and sold shares on nine occasions. The investor's estimated purchase price is $24.2 Million, resulting in a loss of 15%.